Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose M El-Amm

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Surgery|November 5, 2005
Preliminary results with early corticosteroid withdrawal in African American renal allograft recipientsScott A Gruber, Miguel S West, Dale H Sillix, et al.
Clinical Transplantation|February 5, 2009
Outcome predictors in African-American deceased-donor renal allograft recipientsKristian L Brown, Jose M El-Amm, Mona D Doshi, et al.
Clinical Transplantation|July 25, 2007
Sirolimus exposure during the early post-transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipientsAbdolreza Haririan, Katherina Morawski, Miguel S West, et al.
Surgery|October 24, 2007
Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsyXu Zeng, Jose M El-Amm, Mona D Doshi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
Sirolimus-induced angioedemaHani Wadei, Scott A Gruber, Jose M El-Amm, et al.
Transplantation|March 24, 2005
Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipientsAbdolreza Haririan, Katherina Morawski, Dale H Sillix, et al.
Clinical Transplantation|March 3, 2005
Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatusScott A Gruber, James Garnick, Katherina Morawski, et al.
American Journal of Surgery|January 15, 2008
Intermediate-term outcomes of hepatitis C-positive compared with hepatitis C-negative deceased-donor renal allograft recipientsKristian L Brown, Jose M El-Amm, Mona D Doshi, et al.
Clinical Transplantation|July 18, 2006
Infectious complications after kidney transplantation: current epidemiology and associated risk factorsGeorge J Alangaden, Rama Thyagarajan, Scott A Gruber, et al.
Transplantation|July 23, 2008
Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection ratesScott A Gruber, Mona D Doshi, Elizabeth Cincotta, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Surgery|November 5, 2005
Preliminary results with early corticosteroid withdrawal in African American renal allograft recipientsScott A Gruber, Miguel S West, Dale H Sillix, et al.
Clinical Transplantation|February 5, 2009
Outcome predictors in African-American deceased-donor renal allograft recipientsKristian L Brown, Jose M El-Amm, Mona D Doshi, et al.
Clinical Transplantation|July 25, 2007
Sirolimus exposure during the early post-transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipientsAbdolreza Haririan, Katherina Morawski, Miguel S West, et al.
Surgery|October 24, 2007
Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsyXu Zeng, Jose M El-Amm, Mona D Doshi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
Sirolimus-induced angioedemaHani Wadei, Scott A Gruber, Jose M El-Amm, et al.
Transplantation|March 24, 2005
Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipientsAbdolreza Haririan, Katherina Morawski, Dale H Sillix, et al.
Clinical Transplantation|March 3, 2005
Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatusScott A Gruber, James Garnick, Katherina Morawski, et al.
American Journal of Surgery|January 15, 2008
Intermediate-term outcomes of hepatitis C-positive compared with hepatitis C-negative deceased-donor renal allograft recipientsKristian L Brown, Jose M El-Amm, Mona D Doshi, et al.
Clinical Transplantation|July 18, 2006
Infectious complications after kidney transplantation: current epidemiology and associated risk factorsGeorge J Alangaden, Rama Thyagarajan, Scott A Gruber, et al.
Transplantation|July 23, 2008
Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection ratesScott A Gruber, Mona D Doshi, Elizabeth Cincotta, et al.
Pageof 2